miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome
Table 4
Relationship between the expression of ANGPTL2 in serum and the clinicopathological features of obese and nonobese PCOS patients.
Parameters
PCOS-obese (N = 42)
PCOS-nonobese (N = 60)
Pearson r
Pearson r
General comparison
Age
0.0841
0.5966
0.0002
0.9985
BMI
0.0064
0.968
0.045
0.7333
Ferriman–Gallwey score
0.2012
0.2014
0.2853
0.0271
Lipid metabolism index
TC
0.0787
0.6205
−0.0101
0.939
TG
0.0792
0.6181
−0.0094
0.9429
Glucose metabolism index
HOMA-IR
0.2072
0.1879
0.0282
0.8307
FBG
0.0795
0.6168
−0.0728
0.5804
FINS
0.38
0.013
0.2734
0.0345
Sex hormone levels
T
0.4227
0.0053
0.2186
0.0934
E2
0.0784
0.6218
−0.0108
0.935
PRL
−0.3808
0.0129
−0.4387
0.0005
FSH
−0.3625
0.0183
−0.161
0.219
LH
0.0785
0.6212
−0.011
0.9335
LH/FSH
0.2569
0.1005
0.0171
0.8967
Note. Pearson correlation coefficient was used to analyze the data. BMI = body mass index; TC = total cholesterol; TG = total triglyceride; HOMA-IR = HOMA insulin resistance; FBG = fasting blood glucose; FINS = fasting insulin; T = total testosterone; E2 = estradiol; PRL = prolactin; LH = luteinizing hormone; FSH = follicle-stimulating hormone.
